Ibrutinib Approved in the USA for CLL Patient ... - CLL Support

CLL Support

23,963 members40,798 posts

Ibrutinib Approved in the USA for CLL Patient after at least one prior therapy

bkoffman profile image
bkoffmanCLL CURE Hero
3 Replies

Hi friends,

Ibrutinib got a pretty clean approval from the FDA today for CLL.

Anyone who had at least one prior therapy is a candidate for the drug.

For most but not all us that is very good news that means it should be much easier to get the drug outside of a clinical trial.

Our body and blood will still be needed for more clinical trials to broaden the indications and explore appropriate combinations.

I have posted on my speculations on what that might mean on my blog: bkoffman.blogspot.com

Brian

Written by
bkoffman profile image
bkoffman
CLL CURE Hero
To view profiles and participate in discussions please or .
Read more about...
3 Replies
andrewschorr profile image
andrewschorr

Thanks Brian, I know you are excited as you have received this medicine in a trial and it's renewed your life. For the members here, here's the video comment you made a few months ago as research was about to pop into the clinic anytime (no it's happening!): patientpower.info/video/adv... Obviously whether it is available will depend upon country, insurance etc, and funds. That's a whole other story!

bkoffman profile image
bkoffmanCLL CURE Hero

It's a great start, but only a start to getting the new therapies to all who might benefit.

AussieNeil profile image
AussieNeilPartnerAdministrator

Here's OncLive's coverage of the FDA approval of Ibrutinib:

onclive.com/web-exclusives/...

Not what you're looking for?

You may also like...

FDA Approves Venetoclax (VENCLEXTA) For CLL or SLL with or without 17p deletion, who have received at least one prior therapy

FDA Approves Venetoclax (VENCLEXTA) For Chronic Lymphocytic Leukemia or Small Lymphocytic...
lankisterguy profile image
Volunteer

Ibrutinib-Venetoclax is the recommended first-line therapy for fit Arab patients with CLL in the Gulf region

A group of CLL experts from across the Gulf region and an international expert from Germany have...
CLLerinOz profile image
Administrator

Ibrutinib combinations in CLL therapy: scientific rationale and clinical results

From Blood Cancer Journal 29th April 2021 Four strategies have been tested in recent years...
Jm954 profile image
Administrator

Ibrutinib Use in the Real World for CLL

Friends, A short simple interview: ASCO 2014: Dr. Byrd: Ibrutinib in the Real World on the...
bkoffman profile image
CLL CURE Hero

Cost assistance for Ibrutinib in USA

I'm 70 years old and diagnosed with CLL 3 years ago. Been told I need to start Ibrutinib ASAP....
pwebster profile image